Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A.
Praveen VikasLarissa A KordeMark R SomerfieldDawn L HershmanPublished in: JCO oncology practice (2022)